Incensole and incensole acetate, found in incense, are encouraging potent bioactive diterpenic cembrenoids, inhibiting Nuclear Factor-κB activation. Furthermore, incensole acetate elicits psycho-activity in mice by activating the TRPV3 channels in the brain. Starting from crude extracts of the incense species Boswellia papyrifera Hochst., a convenient procedure for the efficient large-scale synthesis of incensole and its acetate is presented. Additionally, a reversed-phase, diode-array-detection, high-performance liquid chromatography (RP-DAD-HPLC) method for the quantification of incensole and incensole acetate is reported, indicating that these two compounds are typical biomarkers for B. papyrifera.
Extracts of frankincense resins become increasingly interesting for pharmaceutical research due to their reported anti-inflammatory, anti-microbial and even anti-tumor activities [1] [2] [3] [4] [5] [6] . Several studies report on the Indian frankincense, Boswellia serrata, used for clinical investigations [7] [8] [9] [10] . Additionally, the isolation and pharmacological activities of compounds from B. carterii (African frankincense, Somalia) are described [11] [12] [13] [14] . Resins of B. papyrifera, another African frankincense species, are described only in a few publications [3, [15] [16] [17] , giving mainly information on typical volatile terpenes thereof. The boswellic acids are considered to be the most pharmacologically active ingredients in these resins, as described extensively in several papers [18] [19] [20] . Moussaieff et al., however, showed that incensole (1) and its acetate (2) ( Figure  1 ), as novel anti-inflammatory diterpenes, may contribute to the overall pharmacological action of frankincense gum preparations by inhibition of Nuclear Factor-κB activation. It is further reported by Moussaieff et al. that incensole-acetate elicits neuronal activity in mice by activating the transient receptor potential cation channel 3 (TRPV3) in the brain [21, 22] . Here, we describe an efficient semi-synthetic isolation method for 1 and 2 from the resin of B. papyrifera. Furthermore, we report on the first quantification of 1 and 2 by reversed-phase, diode-array-detection, high-performance liquid chromatography (RP-DAD-HPLC).
Isolation of incensole and its acetate has been reported by a few authors from B. carterii [11, [21] [22] [23] [24] [25] [26] . Nonetheless, we could not detect compounds 1 and 2 together in B. carterii, B. sacra and B. serrata. Although 1 was found in B. carterii in differing quantities, 2 was not detectable. This result is consistent with the findings of Klein and Obermann, who report on 1, found in low quantities in B. carterii, without mentioning 2 [27] . Interestingly, we found these two compounds in B. papyrifera, according to the results of Hamm et al., Camarda et al. and Obermann [3, 16, 28] . Obermann describes the same pattern for B. papyrifera ("Eritrea") that we obtained by TLC and GC-MS analysis, namely 1 and 2 (two strong brown spots by TLC and relative peak area percentages for 1 = 2.4% and 2 = 3.4% by GC-MS). In B. carterii ("Aden") he neither detected compound 1 nor 2 (Note: B. carterii as Somalia frankincense is shipped to Aden, Yemen, and thus traded as "Aden"-type. Personal Quantification of semivolatile substances, such as 1 and 2, by means of total ion current (GC-MS), however, may suffer from possible thermal decomposition in the injector and different ionization probabilities of different compounds. So, quantification without calibration may lead to uncertain results. Furthermore, the matrix from where these compounds come is very important. Since Hamm et al. extracted powdered samples by headspace solid phase micro extraction (SPME) and Camarda et al. used steam-distilled essential oils, we assume that compounds 1 and 2, as rather less volatile diterpenes, may not have been extracted sufficiently. Thus, we report on a calibrated RP-DAD-HPLC method, using an extraction procedure guaranteeing the complete extraction of target compounds from the resin matrix. Table 1 shows the calibration data and Table 2 presents the observed contents for 1 and 2 in B. papyrifera. As can be seen, 1 and 2 are the main compounds in the neutral fraction of this frankincense resin. Approximately 30-40% of the neutral compounds of the resin refer to the sum of 1 and 2. We did not find comparable amounts for 1 and 2 in B. sacra = B. carterii [29, 30] and B. serrata. Compound 1 was detected in differing quantities, whereas 2 was not observable, at least not in significant quantities. Instead of 1 and 2, B. sacra, B. carterii and B. serrata contain serratol (3; see figure 1 ), another cembrene type molecule already isolated from B. carterii and B. serrata [17, 27, 31] , which is not significantly detectable in B. papyrifera. Even though serratol is reported as a precursor of 1 [27] , there seem to be remarkable (1) and its acetate (2) . Linear regression (y = unit of peak area; x = the weighted sample in mg/mL; plus/minus the ordinate intercept); correlation coefficient (R 2 ); limit of detection (LOD) and the operating range (LOD was determined by multiplication of the noisestandard-deviation by factor = 3; limit of quantitation, LOQ, was determined by multiplication of the noise-standard-deviation by factor = 10; Operating range results from the maximum concentration levels, within which the values were linear).
Compounds
Linear differences in the biogenesis of these frankincense species. Figure 2 shows the HPLC chromatograms of the neutral fractions of these four Boswellia species.
The production of incensole (1) and its acetate (2) in larger quantities is desirable for further investigating their pharmaceutical potential. Therefore, a simple method for the isolation of incensole and its acetate from B. papyrifera, which contains these two diterpenes in relatively high amounts, was developed. Since we recently developed a method for the large scale preparation of 3-Oacetyl-11-oxo-ß-boswellic acid (AKBA) [32] from various frankincense resins, we expected that using a similar strategy would allow us to obtain 2 in large amounts by acetylating the neutral fraction. The synthesis route is shown in scheme 1. The acetylation process can be followed easily by TLC [28] . After 4 hours, 1 is completely converted into 2.
By application of conventional flash column chromatography [33] the acetylated mixture was fractionated, and 14 fractions were obtained (Note: The column was overloaded with material: 29 g of the acetylated mixture was separated on a 10 cm diameter column. A better separation may be achieved if less material, < 20 g, is separated in such a sized column. Nonetheless, we obtained a good compromise between attainable quantity and purity of incensole acetate). Fractions 2, 3 and 4 contained the total amount of 2 in varying purity.
Fraction 3 had the highest quantity and purity (6.9 g, 85% by HPLC control). Through application of preparative HPLC, we were able to purify this fraction further (>99 %) and obtained a yield of 62% (1.28 g from 2.07 g of fraction 3; Note: To achieve a purity >99% results in loss of some of the incensole acetate, since the peak signal was fractionated generously, see also supplementary data). Approximately calculated, a total yield of 3.84 g from 6.9 g (62%, purity > 99%) could be obtained, if fraction 3 were purified completely, and thus, leading to a total yield of 5% referred to the overall weighed amount of resin. Calculations for the purification of incensole acetate are shown in Table 3 . The detailed preparative chromatographic procedure is explained in the experimental section (isolation of incensole acetate). Incensole acetate and incensole can be converted easily into each other, as shown in Scheme 1. The detailed synthesis procedure is described in the experimental section (Deacetylation of incensole acetate; Acetylation of incensole).
In summary, the method described here allows the semi-preparative synthesis of incensole acetate from the neutral fraction of B. papyrifera in large quantities. This is simply achieved by acetylation of incensole in the crude neutral fraction and thus provides a convenient method for the isolation of these two chemical entities. By conventional deacetylation and acetylation reactions, both diterpenes can be converted into one another. Furthermore, a RP-DAD-HPLC method for the qualitative and quantitative determination of incensole and its acetate in the neutral These were processed with MestReC software, version 4.9.9.6. NMR spectra were calibrated against the residual solvent peak δ C (CDCl 3 ) = 77.0 ppm and δ H (CDCl 3 ) = 7.26 ppm.
Olibanum sample preparation:
Separation of the neutral compounds from the acid fraction was achieved by cooling the resin (20 g) in a freezer (1-2 h) and powdering it in an electrical mixer. The powder was extracted overnight with 1.5 L diethyl ether using a Soxhlet apparatus. The solvent was removed under vacuum and a crude yellow and fragrant extract was obtained (ca. 10 -14 g). This was dissolved in 200 mL diethyl ether and washed in a separating funnel with 5% KOH solution (3 x 50 mL). The combined aqueous phases were extracted with diethyl ether again (3 x 30 mL) and all organic phases were combined, washed with brine and dried using MgSO 4 . After filtration, the solvent was removed under vacuum, leading to the orange colored neutral fraction (ca. 5 -7 g), containing 1 and 2 (Boswellia papyrifera).
Acetylation of the neutral fraction from Boswellia papyrifera:
Twenty-five g of the orange colored neutral compounds were dissolved in 30 mL dichloromethane in a 500 mL three-necked flask. Eighteen mL of pyridine (17.4 g, 0.22 mol), 20.4 mL of acetic anhydride (20.4 g, 0.2 mol) and 3 g DMAP (0.025 mol) were added, successively. The temperature was raised till the reaction mixture started to reflux gently. It was stirred for 4 h. After the reaction was complete, the mixture was quenched with 300 mL 1 N HCl. The phases were separated and the aqueous phase extracted with diethyl ether (3 x ca. 100 mL). The combined organic phases were dried with MgSO 4 and after filtration and evaporation in vacuo an orange oil was obtained (yield: 28.7 g).
Isolation of incensole acetate (flash and instrumental preparative chromatography):
The orange oil (28.7 g) was dissolved in 30 mL DCM. Normal phase silica gel flash chromatography (column diameter: 10 cm) was performed by using an eluent consisting of 6
parts light petroleum and one part diethyl ether (6:1). Fourteen fractions were collected, all of which were evaporated in vacuo. Each fraction contained a yellow oil. Fractions 2 (3.1 g, 43% 2), 3 (6.9 g, 85% 2) and 4 (2.2 g, 61% 2) contained incensole acetate in large quantities. Fraction 3, as the fraction of highest purity (85% by HPLC control), was further purified by preparative HPLC. The whole amount of fraction 3 (6.9 g) was dissolved in 100 mL methanol, sonicated and 30 mL (2.07 g) of this solution was filtered (0.2 µm) and used for preparative HPLC (The remaining 70 mL, 4.83 g, was evaporated again and stored at -30°C). The following HPLC conditions were used: As preparative column a YMC-Pack Pro C18 RS (250 x 20 mm I.D. S-5 µm, 8 nm; YMC, Dinslaken, Germany); flow rate = 19 mL/min; T = room temperature (ca. 25°C); eluent: 100% methanol, injection volume = 3 mL, total injections = 10 (30 mL, c = 69 mg/mL); three fractions were collected (see supplementary material. Note: Alternative preparation conditions on a NUCLEODUR 100-5 C18 ec, 250 x 21 mm I.D., Machery & Nagel, Düren, Germany, preparative column: flow rate = 27.6 mL/min; T = room temperature, ca. 25°C; eluent: methanol 96% and water 4%. These conditions give similar resolution for purifying incensole acetate); the middle fraction contained 1.28 g (yield: 62% of total 2.07 g) referring to compound 2 with a purity higher than 99%. The remaining fraction 3 (4.8 g) is stable for 12 months at -30°C.
Deacetylation of incensole acetate:
The isolated incensole acetate (350 mg, 1 mmol) was dissolved in 10 mL 1 N KOH in iPrOH. The reaction mixture was refluxed for 3 h. After cooling to room temperature, iPrOH was mostly removed in vacuo. The residue was acidified with 20 mL 1 N HCl and extracted with DCM (3 x 10 mL). The combined organic extracts were dried with MgSO 4 . After filtration, the solvent was evaporated in vacuo to give a colorless oil (yield: 268 mg, 0.87 mmol, ca. 90%; purity: > 99%). Optional: purification by column chromatography or preparative HPLC.
Acetylation of incensole:
Incensole (25.0 mg, 82 µmol) was dissolved in 5 mL DCM, and 30 µL of pyridine (30 µg, 372 µmol), 33 µL of acetic anhydride (32 µg, 326 µmol) and 6 mg of DMAP (49 µmol) were added successively. The reaction mixture was heated until it started to reflux gently. It was stirred for 4 h at that temperature. After reaction was complete, the mixture was cooled to room temperature and quenched with 40 mL 1 N HCl. The organic phase was saved and the aqueous phase was extracted with diethyl ether (3 x ca. 10 mL). The combined organic phases were dried with MgSO 4 and after filtration and evaporation in vacuo, a colorless oil was obtained (yield: 26.6 mg, 76 µmol, ca. 93%; purity: > 98%). Optional: Purification by column chromatography or preparative HPLC.
Generation of standards (HPLC analysis):
Incensole (1) and incensole acetate (2) were isolated from Boswellia papyrifera using pH dependent liquid-liquid extraction, flash column chromatography and instrumental preparative chromatography. Characterisation of 1 and 2 was carried out by 1D and 2D NMR spectroscopy and MS. Purity of the isolated compounds was determined by RP-DAD-HPLC and TLC and was >99% (HPLC). For the preparation of standards, 5.3 mg of 1 and 5.9 mg of 2 were dissolved in 8 mL methanol using a 10 mL volumetric flask and sonicated for 15 mins. After sonication, 2 mL methanol was added to give the final concentration in solution (0.53 mg/mL for 1 and 0.59 mg/mL for 2). The stock solution was filtered (0.2 µm; Filtropur S; Sarstedt, Nürnbrecht, Germany). From the filtered stock solution 5 additional standard solutions were generated by diluting each successively with factor 0.5, providing a linear operating range from 0.017 -0.53 mg/mL for 1 and 0.018 -0.59 mg/mL for 2. Each standard concentration was injected 3 times. The determination was realised by external calibration (peak area plotted against sample concentration; see supplementary data). The basic calibration data is shown in Table 1 .
Supplementary data: Analytical quantitation chromatograms for 1 and 2 at three detection wavelengths and the statistical raw data are contained in the supplementary data, as well as chromatograms of the isolation steps for compound 2 (purity after silica-gel column chromatography and an example of a preparative chromatogram for fractionation of compound 2).
